Non Invasive Oral Cancer Screening Among HIV Infected Individuals

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 26, 2021

Study Completion Date

July 26, 2021

Conditions
Malignant Neoplasms of Mesothelial and Soft TissueHuman Immunodeficiency Virus
Interventions
BEHAVIORAL

Screening Interview

Participants asked about demographic information, and questions about history of tobacco, alcohol, and mouthwash use. Interview lasts about 7 minutes.

DEVICE

Carbon Monoxide Test

Carbon monoxide testing given to participants at baseline. Participants blow into a device that measures the amount of carbon monoxide in the lungs.

BEHAVIORAL

Self-Help Materials

"Participants who want to stop smoking are given referral information for a tobacco cessation program at baseline.~Participants with premalignant and malignant oral lesions \[PMOL\]) given printed materials and web-based programs for tobacco and alcohol cessation."

PROCEDURE

Visual Oral Screening Examination

Intraoral exam performed under incandescent (white light) conditions at baseline, and again two weeks later.

PROCEDURE

Direct Fluorescent Oral Visualization Examination

Intraoral exam performed under reduced room lighting with a handheld autofluorescence imaging device at baseline, and again two weeks later.

PROCEDURE

Oral Biopsy

Premalignant and malignant oral lesions \[PMOL\]) still present 2 weeks after oral exam are biopsied.

Trial Locations (1)

77006

Bering Omega/Houston Area Community Services, Houston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

collaborator

The University of Texas Health Science Center, Houston

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT02823847 - Non Invasive Oral Cancer Screening Among HIV Infected Individuals | Biotech Hunter | Biotech Hunter